...
首页> 外文期刊>Journal of drug targeting >Lentivirus-mediated shRNA targeting Nanog inhibits cell proliferation and attenuates cancer stem cell activities in breast cancer
【24h】

Lentivirus-mediated shRNA targeting Nanog inhibits cell proliferation and attenuates cancer stem cell activities in breast cancer

机译:慢病毒介导的shRNA靶向纳米瘤抑制细胞增殖并衰减乳腺癌中的癌症干细胞活性

获取原文
获取原文并翻译 | 示例
           

摘要

Emerging evidences suggest that cancer stem cells (CSCs) are responsible for tumor growth, metastasis and treatment resistance. Nanog is one of the transcription factors that are essential for stem cellular physiology process. Previous studies reported that Nanog was detected in breast cancer and other solid tumors and indicated that it has oncogenic characteristics. However, expression feature of Nanog in breast cancer stem cells (BCSCs) enriched population and its biological function in BCSCs is poorly understood. In this study, CD44 + CD24- fraction sorting with Fluorescence Activated Cell Sorter and mammosphere culture were used for enriching BCSCs. We report here that Nanog was highly expressed in CSCs-enriched population from the breast cancer cells, as well as stemness-associated genes. In addition, we employed the lentivirus-mediated shRNA targeting Nanog to investigate function of Nanog in BCSCs. We found that targeted inhibition of Nanog could suppress proliferation and colony formation in breast cancer cells. Further studies showed that targeted inhibition of Nanog resulted in a decrease of BCSCs activities, including mammosphere formation, CD44 + CD24- proportion and expressions of stemness-associated genes. These data therefore suggest that Nanog possesses important function in BCSCs and targeted inhibition of Nanog may provide a novel means of targeting and eliminating BCSCs.
机译:新的证据表明,肿瘤干细胞(CSCs)与肿瘤生长、转移和治疗耐药性有关。Nanog是干细胞生理过程中必不可少的转录因子之一。此前的研究报告称,在乳腺癌和其他实体瘤中检测到Nanog,并表明其具有致癌特征。然而,Nanog在富含乳腺癌干细胞(BCSCs)的人群中的表达特征及其在BCSCs中的生物学功能尚不清楚。在本研究中,CD44+CD24-组分分选与荧光激活细胞分选机和乳腺球培养用于富集BCSCs。我们在此报告,Nanog在来自乳腺癌细胞的CSCs富集群体中高度表达,以及干细胞相关基因。此外,我们利用慢病毒介导的靶向Nanog的shRNA来研究Nanog在BCSCs中的功能。我们发现,靶向抑制Nanog可以抑制乳腺癌细胞的增殖和集落形成。进一步的研究表明,靶向抑制Nanog导致BCSCs活性降低,包括乳腺球形成、CD44+CD24-比例和干细胞相关基因的表达。因此,这些数据表明Nanog在BCSCs中具有重要功能,靶向抑制Nanog可能为靶向和消除BCSCs提供一种新的手段。

著录项

  • 来源
    《Journal of drug targeting》 |2016年第10期|共11页
  • 作者单位

    Shanghai Jiao Tong Univ Ruijin Hosp Dept Oncol Sch Med Shanghai 200025 Peoples R China;

    Shanghai Jiao Tong Univ Ruijin Hosp Dept Oncol Sch Med Shanghai 200025 Peoples R China;

    Shanghai Jiao Tong Univ Ruijin Hosp Dept Oncol Sch Med Shanghai 200025 Peoples R China;

    Shanghai Jiao Tong Univ Dept Oncol Suzhou Kowloon Hosp Sch Med Suzhou 215021 Peoples R China;

    Chinese Acad Sci Inst Hlth Sci Shanghai Inst Biol Sci Shanghai Peoples R China;

    Shanghai Jiao Tong Univ Ruijin Hosp Dept Oncol Sch Med Shanghai 200025 Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

    Breast cancer; Nanog; targeted therapy; cancer stem cells; RNA interference;

    机译:乳腺癌;纳米;靶向治疗;癌症干细胞;RNA干扰;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号